Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GLMD
#5040
Galmed Pharmaceuticals Ltd.
0.7
1
USD
-6.58%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-6.58%
Monthly Change
+9.23%
6 month change
-49.65%
Year Change
-44.53%
Previous Close
0.7
6
Open
0.7
1
Bid
Ask
Low
0.7
1
High
0.7
1
Volume
22
Markets
US Stock Market
Healthcare
GLMD
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
118.48 K
139.38 K
140.02 K
420.44 K
1.65 M
6.58 M
8.8 M
Valuation ratios
Enterprise value
59.38 M
44.22 M
16.66 M
269.43 K
1.5 M
1.8 M
20.23 M
Price to earnings ratio
—
-1.38
-1
0.18
0.39
0.31
-0.12
Price to sales ratio
—
1 790.71
-496.78
27.68
-74.23
1.26
—
Price to cash flow ratio
—
-1.36
-0.97
-0.2
-0.5
-0.51
-2.18
Price to book ratio
—
1.47
1.33
0.09
0.18
0.21
1.81
Enterprise value to EBITDA ratio
-14.52
-1.3
-0.9
0.09
-0.1
-0.16
—
Profitability ratios
Return on assets %
-0.55
-0.89
-1.08
-0.42
-0.41
-0.55
-0.25
Return on equity %
-0.65
-1.06
-1.33
-0.5
-0.46
-0.65
-0.3
Return on invested capital %
-402.77
-749.41
-3 600.41
-898.44
-524.21
-434.29
—
Gross margin %
—
-477.9
100
100
100
100
—
Operating margin %
—
-132 K
49.13 K
-17.15 K
15.79 K
-230.36
—
EBITDA margin %
—
-131.83 K
49.14 K
-16.88 K
15.64 K
-229.77
—
Net margin %
—
-129.87 K
49.63 K
-15.71 K
18.79 K
-400.19
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.47
6.13
4.76
4.81
7.42
6.55
23.54
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
-0
0
-0
0.14
—
Solvency ratios
Debt to assets ratio
—
0.04
0.05
0.05
0.05
0.05
0.19
Debt to equity ratio
—
0.05
0.06
0.07
0.05
0.05
0.23
Long term debt to total assets ratio
—
0.03
0.03
0.05
0.05
0.05
0.18
Long term debt to total equity ratio
—
0.03
0.04
0.06
0.05
0.05
0.21
Per share metrics
Operating cash flow per share
—
-240.7
-132.45
-26.59
-6.32
-1.46
-1.1
EBIT per share
—
-241.49
-126.62
-32.27
-6.79
-1.38
—
EBITDA per share
—
-241.18
-126.64
-32.19
-6.72
-1.37
—
Total debt per share
—
10.56
5.37
3.95
0.94
0.2
10.45
Cash per share
—
254.54
98.69
44.89
12.73
2.55
158.86
Net current asset value per share
—
263.84
105.41
57.36
17.32
4.32
184.42
Tangible book value per share
—
223.17
96.1
60.14
17.54
3.66
177.43
Working capital per share
—
220.81
83.26
45.45
14.99
3.66
147.36
Book value per share
—
223.17
96.1
60.14
17.54
3.66
177.43
News
Morning News Wrap-Up 4/9/26: Today’s Biggest Stock Market Stories! - TipRanks.com
Galmed Pharmaceuticals schedules special shareholder meeting for March 4
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice
Galmed to present data on Aramchol’s potential in liver cancer
Galmed stock rises after patent grant for MASH combo therapy
Galmed receives patent for combination therapy in South Korea
Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook
Galmed reports $19.2 million cash position, advances Aramchol programs
Galmed stock soars after promising cancer treatment research results
Galmed reports 3-drug combo enhances cancer treatment efficacy
Galmed Pharmaceuticals schedules annual general meeting for October 28
Galmed to invest up to $10M in digital assets as part of new strategy